News & Insights
News & Insights
From research breakthroughs and company milestones to opportunities to develop your career as we shape the future of radionuclide therapy.
From research breakthroughs and company milestones to opportunities to develop your career as we shape the future of radionuclide therapy.
Feb 4, 2026
World Cancer Day 2026
King's College London sat down with our CSO, Prof. Tim Witney, for World Cancer Day.
Feb 4, 2026
World Cancer Day 2026
King's College London sat down with our CSO, Prof. Tim Witney, for World Cancer Day.
Oct 8, 2025
Latest press release
Read our press release detailing the conclusion of our recent funding round.
Oct 8, 2025
Latest press release
Read our press release detailing the conclusion of our recent funding round.
Sep 22, 2025
Launch announcement
Nuclide Therapeutics secures £5 million investment to spearhead first-in-human clinical trials.
Sep 22, 2025
Launch announcement
Nuclide Therapeutics secures £5 million investment to spearhead first-in-human clinical trials.
Feb 4, 2026
World Cancer Day 2026
King's College London sat down with our CSO, Prof. Tim Witney, for World Cancer Day.
Sep 22, 2025
Launch announcement
Nuclide Therapeutics secures £5 million investment to spearhead first-in-human clinical trials.
Oct 8, 2025
Latest press release
Read our press release detailing the conclusion of our recent funding round.
Connect with us
Email us, and keep updated on our clinical trial pipeline on LinkedIn.
Connect with us
Email us, and keep updated on our clinical trial pipeline on LinkedIn.
© 2026 Nuclide Therapeutics, All rights reserved
© 2026 Nuclide Therapeutics, All rights reserved
© 2026 Nuclide Therapeutics, All rights reserved